Evaluation of smart microcarriers for high-density culture and enzymefree harvesting of primary dermal sheath cells and fibroblasts

RepliCel is a regenerative medicine company that develops autologous cell therapies to treat chronic tendinosis, UV-damaged or aged skin, and pattern baldness. The cells in this technology are isolated from skin biopsies obtained from patients. However, because of limited available tissue samples, RepliCel seeks novel technologies to improve their cell culture process, which is currently time-consuming, labor-intensive, and low throughput.

Isolation, characterization and culture maintenance of stem cells from human hair follicle mesenchyme Year Two

Stem cells and other pluripotent cells are under active investigation for the development of new therapeutic treatments to regenerate and repair diseased and damaged tissues. Published studies indicate that some mesenchymal cells derived from adult human hair follicles exhibit stem cell properties and can form different cells types if they are given specific biological signals without the need to genetically modify the cells.

Isolation, characterization and culture maintenance of stem cells from human hair follicle mesenchyme

Stem cells and other pluripotent cells are under active investigation for the development of new therapeutic treatments to regenerate and repair diseased and damaged tissues. Published studies indicate that some mesenchymal cells derived from adult human hair follicles exhibit stem cell properties and can form different cells types if they are given specific biological signals without the need to genetically modify the cells.